Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Brain : a Journal of Neurology
|
April 25, 2015
Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9
Maren Lindner, Katja Thümmler, Ariel Arthur, et al.
Acta Neuropathologica
|
September 7, 2020
Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis
Laura Starost, Maren Lindner, Martin Herold, et al.
Acta Neuropathologica
|
July 8, 2016
The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion
Stephanie Hucke, Martin Herold, Marie Liebmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 27, 2022
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound
Claudia Janoschka, Maren Lindner, Nils Koppers, et al.
Brain : a Journal of Neurology
|
June 6, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity
Tobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, et al.
Science Translational Medicine
|
May 3, 2019
Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects
Luisa Klotz, Melanie Eschborn, Maren Lindner, et al.
Cell Research
|
October 27, 2021
K<sub>2P</sub>18.1 translates T cell receptor signals into thymic regulatory T cell development
Tobias Ruck, Stefanie Bock, Steffen Pfeuffer, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Brain : a Journal of Neurology
|
April 25, 2015
Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9
Maren Lindner, Katja Thümmler, Ariel Arthur, et al.
Acta Neuropathologica
|
September 7, 2020
Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis
Laura Starost, Maren Lindner, Martin Herold, et al.
Acta Neuropathologica
|
July 8, 2016
The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion
Stephanie Hucke, Martin Herold, Marie Liebmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 27, 2022
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound
Claudia Janoschka, Maren Lindner, Nils Koppers, et al.
Brain : a Journal of Neurology
|
June 6, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity
Tobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, et al.
Science Translational Medicine
|
May 3, 2019
Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects
Luisa Klotz, Melanie Eschborn, Maren Lindner, et al.
Cell Research
|
October 27, 2021
K<sub>2P</sub>18.1 translates T cell receptor signals into thymic regulatory T cell development
Tobias Ruck, Stefanie Bock, Steffen Pfeuffer, et al.
Page
of 3